39 related articles for article (PubMed ID: 10512930)
1. ADMA injures the glomerular filtration barrier: role of nitric oxide and superoxide.
Sharma M; Zhou Z; Miura H; Papapetropoulos A; McCarthy ET; Sharma R; Savin VJ; Lianos EA
Am J Physiol Renal Physiol; 2009 Jun; 296(6):F1386-95. PubMed ID: 19297451
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of endothelial dysfunction in resistance arteries from patients with end-stage renal disease.
Luksha L; Stenvinkel P; Hammarqvist F; Carrero JJ; Davidge ST; Kublickiene K
PLoS One; 2012; 7(4):e36056. PubMed ID: 22563439
[TBL] [Abstract][Full Text] [Related]
3. Angiotensin II-induced endothelial dysfunction: Impact of sex, genetic background, and rho kinase.
Kinzenbaw DA; Langmack L; Faraci FM
Physiol Rep; 2022 Jun; 10(11):e15336. PubMed ID: 35681278
[TBL] [Abstract][Full Text] [Related]
4. Serum L-arginine and endogenous methylarginine concentrations predict irritable bowel syndrome in adults: A nested case-control study.
McEvoy MA; Attia JR; Oldmeadow C; Holliday E; Smith WT; Mangoni AA; Peel R; Hancock SJ; Walker MM; Talley NJ
United European Gastroenterol J; 2021 Sep; 9(7):809-818. PubMed ID: 34431615
[TBL] [Abstract][Full Text] [Related]
5. Arginine Derivatives in Cerebrovascular Diseases: Mechanisms and Clinical Implications.
Grosse GM; Schwedhelm E; Worthmann H; Choe CU
Int J Mol Sci; 2020 Mar; 21(5):. PubMed ID: 32150996
[TBL] [Abstract][Full Text] [Related]
6. Acid-Sensing Ion Channels: Novel Mediators of Cerebral Vascular Responses.
Faraci FM; Taugher RJ; Lynch C; Fan R; Gupta S; Wemmie JA
Circ Res; 2019 Oct; 125(10):907-920. PubMed ID: 31451088
[TBL] [Abstract][Full Text] [Related]
7. Serum Asymmetric and Symmetric Dimethylarginine and Morbidity and Mortality in Hemodialysis Patients.
Shafi T; Hostetter TH; Meyer TW; Hwang S; Hai X; Melamed ML; Banerjee T; Coresh J; Powe NR
Am J Kidney Dis; 2017 Jul; 70(1):48-58. PubMed ID: 28089476
[TBL] [Abstract][Full Text] [Related]
8. Effects of asymmetric dimethylarginine on renal arteries in portal hypertension and cirrhosis.
Segarra G; Cortina B; Mauricio MD; Novella S; Lluch P; Navarrete-Navarro J; Noguera I; Medina P
World J Gastroenterol; 2016 Dec; 22(48):10545-10556. PubMed ID: 28082806
[TBL] [Abstract][Full Text] [Related]
9. Asymmetric Dimethylarginine and Hepatic Encephalopathy: Cause, Effect or Association?
Czarnecka A; Milewski K; Zielińska M
Neurochem Res; 2017 Mar; 42(3):750-761. PubMed ID: 27885576
[TBL] [Abstract][Full Text] [Related]
10. Asymmetric dimethylarginine as a mediator of vascular dysfunction in cirrhosis.
Lluch P; Segarra G; Medina P
World J Gastroenterol; 2015 Aug; 21(32):9466-75. PubMed ID: 26327755
[TBL] [Abstract][Full Text] [Related]
11. Increased circulatory asymmetric dimethylarginine and multiple organ failure: bile duct ligation in rat as a model.
Sheen JM; Chen YC; Tain YL; Huang LT
Int J Mol Sci; 2014 Mar; 15(3):3989-4006. PubMed ID: 24603538
[TBL] [Abstract][Full Text] [Related]
12. Serum methylarginines and spirometry-measured lung function in older adults.
McEvoy MA; Schofield PW; Smith WT; Agho K; Mangoni AA; Soiza RL; Peel R; Hancock SJ; Carru C; Zinellu A; Attia JR
PLoS One; 2013; 8(5):e58390. PubMed ID: 23690915
[TBL] [Abstract][Full Text] [Related]
13. Asymmetric dimethyarginine as marker and mediator in ischemic stroke.
Chen S; Li N; Deb-Chatterji M; Dong Q; Kielstein JT; Weissenborn K; Worthmann H
Int J Mol Sci; 2012 Nov; 13(12):15983-6004. PubMed ID: 23443106
[TBL] [Abstract][Full Text] [Related]
14. Bioanalytical profile of the L-arginine/nitric oxide pathway and its evaluation by capillary electrophoresis.
Boudko DY
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 May; 851(1-2):186-210. PubMed ID: 17329176
[TBL] [Abstract][Full Text] [Related]
15. Effects of some guanidino compounds on human cerebral arteries.
Segarra G; Medina P; Ballester RM; Lluch P; Aldasoro M; Vila JM; Lluch S; Pelligrino DA
Stroke; 1999 Oct; 30(10):2206-10; discussion 2210-11. PubMed ID: 10512930
[TBL] [Abstract][Full Text] [Related]
16. Contractile effects of arginine analogues on human internal thoracic and radial arteries.
Segarra G; Medina P; Vila JM; Martínez-León JB; Ballester RM; Lluch P; Lluch S
J Thorac Cardiovasc Surg; 2000 Oct; 120(4):729-36. PubMed ID: 11003756
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of nitric oxide activity by arginine analogs in human renal arteries.
Segarra G; Medina P; Vila JM; Chuan P; Domenech C; Torondel B; Lluch A
Am J Hypertens; 2001 Nov; 14(11 Pt 1):1142-8. PubMed ID: 11724214
[TBL] [Abstract][Full Text] [Related]
18. Effects of guanidino and uremic compounds on nitric oxide pathways.
MacAllister RJ; Whitley GS; Vallance P
Kidney Int; 1994 Mar; 45(3):737-42. PubMed ID: 7515129
[TBL] [Abstract][Full Text] [Related]
19. Asymmetric dimethylarginine, derangements of the endothelial nitric oxide synthase pathway, and cardiovascular diseases.
Böger RH; Bode-Böger SM
Semin Thromb Hemost; 2000; 26(5):539-45. PubMed ID: 11129410
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
